The goal of this research study is to understand the effect of inhalation approaches in reducing nausea in cancer patients.
Rate current severity of acute/chronic nausea >= 4 on NRS (Numeric Rating Scale)
Diagnosis of cancer
Able to read/write in English
Referred to supportive care service as an inpatient or outpatient
Received anti-emetics in the last 30 minutes
Received medical procedures (e.g. blood draws) which required exposure of isopropyl alcohol in the last 30 minutes
Inability to inhale through nares (including recent upper respiratory infection)
Known allergy to isopropyl alcohol
Parallel
Isopropyl Alcohol
DrugGiven via nasal inhalation
Placebo
Other interventionGiven via nasal inhalation
Questionnaire Administration
Other interventionAncillary studies
Change in nausea
The mean change in nausea level will be compared between the two arms by two sample t-test. In case there's any violation in the underlying assumptions (e.g. normality, equality of variance, etc.) proper transformation (e.g. logarithm, square root, etc.) or non-parametric methods (Wilcoxon rank sum test) will be applied.
Click on the lead sponsor to view all of their trials.
M.D. Anderson Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
